← Back to Search

Caregiving Skills Training for Brain Cancer

N/A

Recruiting

Led By Kathryn Milbury, MA,PHD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion and average of 1 year.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether a caregiving skills intervention can improve the psychological health of caregivers and patients, as well as reduce patient cancer symptoms and healthcare utilization.

Who is the study for?

This trial is for family caregivers of patients with high-grade gliomas (HGG). Caregivers can be spouses, parents, or adult children. Both the caregiver and patient must be over 18, speak English, and consent to participate. Patients should have a moderate ability to perform daily activities (KPS of 50-100). Excluded are caregivers in regular psychotherapy, patients with cognitive issues affecting survey completion, minors under 18 years old, and pregnant patients.

What is being tested?

The study tests a training program designed to help family caregivers manage their caregiving responsibilities better. It aims to improve psychological health for both caregiver and patient while enhancing caregiving skills and adjusting to the caregiver role. The intervention also seeks to reduce cancer-related symptoms in patients.

What are the potential side effects?

Since this trial involves questionnaires and assessments rather than medical treatments or drugs, there are no typical side effects like those associated with medications or surgical procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion and average of 1 year.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion and average of 1 year.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion and average of 1 year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

M. D. Anderson Symptom Inventory (MDASI) questionnaires

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Caregiver Intervention SessionsExperimental Treatment1 Intervention

Caregiver will take part in 4 caregiver intervention sessions. The first 2 sessions will take place in the Simulation Center at the hospital when you are scheduled for treatment or a follow-up appointment. The remaining 2 sessions will be done remotely using a videoconference platform (such as Zoom) and will focus on discussing your caregiver's role and experiences and suggesting coping and self-care strategies.

Group II: Baseline AssessmentExperimental Treatment1 Intervention

Participants will be asked to complete a baseline assessment of questionnaires that will ask: * Demographic information (such as your age, sex, and race) * Psychological and physical health

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Questionnaires

2013

Completed Phase 2

~4280

Do I qualify?Apply below to find out